Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122825164 | 12282516 | 4 | F | 20160330 | 20160803 | 20160419 | 20160816 | EXP | US-CELGENEUS-USA-2016043898 | CELGENE | 65.36 | YR | F | Y | 0.00000 | 20160816 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122825164 | 12282516 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | Y | U | 20785 | 50 | MG | CAPSULES | QD | |||||
| 122825164 | 12282516 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 50-800MG | Y | U | 20785 | CAPSULES | QD | ||||||
| 122825164 | 12282516 | 3 | SS | THALOMID | THALIDOMIDE | 1 | Oral | Y | U | 20785 | 50 | MG | CAPSULES | QD | |||||
| 122825164 | 12282516 | 4 | SS | THALOMID | THALIDOMIDE | 1 | Oral | Y | U | 20785 | 200 | MG | CAPSULES | QD | |||||
| 122825164 | 12282516 | 5 | SS | THALOMID | THALIDOMIDE | 1 | Oral | Y | U | 20785 | 200 | MG | CAPSULES | QD | |||||
| 122825164 | 12282516 | 6 | C | KCL | POTASSIUM CHLORIDE | 1 | Unknown | 0 | 20 | MG | UNKNOWN | QD | |||||||
| 122825164 | 12282516 | 7 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | 0 | 5 | MG | UNKNOWN | QD | |||||||
| 122825164 | 12282516 | 8 | C | REMICADE | INFLIXIMAB | 1 | Intravenous drip | 0 | UNKNOWN | QOW | |||||||||
| 122825164 | 12282516 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | 125 | UG | UNKNOWN | QD | |||||||
| 122825164 | 12282516 | 10 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | 0 | 80 | MG | UNKNOWN | QD | |||||||
| 122825164 | 12282516 | 11 | C | Oxycodone | OXYCODONE | 1 | Unknown | 0 | 5 | MG | UNKNOWN | Q6H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122825164 | 12282516 | 1 | Sarcoidosis |
| 122825164 | 12282516 | 6 | Product used for unknown indication |
| 122825164 | 12282516 | 7 | Product used for unknown indication |
| 122825164 | 12282516 | 8 | Product used for unknown indication |
| 122825164 | 12282516 | 9 | Product used for unknown indication |
| 122825164 | 12282516 | 10 | Product used for unknown indication |
| 122825164 | 12282516 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122825164 | 12282516 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122825164 | 12282516 | Fall | |
| 122825164 | 12282516 | Pneumonia | |
| 122825164 | 12282516 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122825164 | 12282516 | 1 | 200506 | 0 | ||
| 122825164 | 12282516 | 2 | 200509 | 0 | ||
| 122825164 | 12282516 | 3 | 20140213 | 0 | ||
| 122825164 | 12282516 | 4 | 201412 | 0 | ||
| 122825164 | 12282516 | 5 | 20150202 | 0 |